Bristol-Myers Squibb Company PFD CONV 2 (BMYMP)
Data as of September 22, 2026 · Drug Manufacturers - General
Stockbruh grade: Mixed 2/5 metrics rated Sunny
What does Bristol-Myers Squibb Company PFD CONV 2 do?
🔬💊 Bristol-Myers Squibb, based in the USA, is a leading company in discovering, developing, and marketing drugs for a range of health issues. With a focus on immuno-oncology, they're dedicated to revolutionizing cancer treatment. Their iconic products give hope for a healthier future..
Key Numbers
| Metric | Rating | What it means |
|---|
| Returns (5Y) | ⛅ Moderate | 5-year price performance |
| Profitability | ☀️ Strong | Net margin & return on equity |
| Growth | ⛅ Moderate | Revenue & earnings trend |
| Earnings | ☀️ Strong | EPS vs analyst expectations |
| Cash & Debt | ⛅ Moderate | Balance sheet strength |
| Price | $400.00 | Market Cap | — |
| Exchange | Other OTC | | |
Plain-English Analysis
What's it worth?
Performance has been moderate. Sign up free to see Stockbruh's full valuation analysis including price ratios and plain-English commentary.
How the business works
🔬💊 Bristol-Myers Squibb, based in the USA, is a leading company in discovering, developing, and marketing drugs for a range of health issues. With a focus on immuno-oncology, they're dedicated to revolutionizing cancer treatment. Sign up free for competitor and revenue breakdown ↗
Are they building the future?
Growth is mixed — some positive signals, but not consistent. Sign up free for Stockbruh's full growth breakdown.
What's ahead?
Recent earnings have been strong, meeting or beating analyst expectations. Sign up free for earnings history, EPS trends, and what analysts are forecasting next.